Omega Fund Management

Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BCAX, NUVB, KMTS, BBOT, BBNX, and represent 92.47% of Omega Fund Management's stock portfolio.
  • Added to shares of these 1 stock: Odyssey Therapeutics.
  • Started 1 new stock position in Odyssey Therapeutics.
  • Reduced shares in these 2 stocks: BCAX (-$17M), REPL.
  • Sold out of its position in REPL.
  • Omega Fund Management was a net seller of stock by $-19M.
  • Omega Fund Management has $186M in assets under management (AUM), dropping by 13.81%.
  • Central Index Key (CIK): 0001637359

Tip: Access up to 7 years of quarterly data

Positions held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bicara Therapeutics Common Stock (BCAX) 29.1 $54M -23% 1.8M 29.69
 View chart
Nuvation Bio Common Stock Class A (NUVB) 24.7 $46M 8.1M 5.68
 View chart
Kestra Med Technologies Common Stock (KMTS) 14.0 $26M 1.0M 25.44
 View chart
BridgeBio Oncology Therapeutics Common Stock (BBOT) 13.5 $25M 3.3M 7.62
 View chart
Beta Bionics Common Stock (BBNX) 11.1 $21M 1.3M 15.67
 View chart
Alumis Common Stock (ALMS) 3.7 $6.8M 241k 28.14
 View chart
Sana Biotechnology Common Stock (SANA) 1.6 $2.9M 844k 3.49
 View chart
ImageneBio Common Stock (IMA) 1.4 $2.7M 455k 5.90
 View chart
enGene Holdings Common Stock 0.8 $1.5M 876k 1.73
 View chart
Odyssey Therapeutics Common Stock 0.0 $54k NEW 2.9k 18.71
 View chart

Past Filings by Omega Fund Management

SEC 13F filings are viewable for Omega Fund Management going back to 2014

View all past filings